HC Wainwright & Co. Maintains Buy on Applied DNA Sciences, Adjusts Price Target To $1.5
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has maintained a Buy rating on Applied DNA Sciences (NASDAQ:APDN) and adjusted the price target to $1.5 from $2.

February 09, 2024 | 6:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on Applied DNA Sciences, adjusting the price target to $1.5 from $2.
The maintenance of a Buy rating by a reputable analyst firm like HC Wainwright & Co. generally signals confidence in the company's future performance. The adjustment of the price target, despite being a decrease, still indicates a potential upside from current levels, assuming the stock is trading below $1.5. This could lead to positive sentiment among investors in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100